APA (7th ed.) Citation

S, S., EM, B., A, C., D, H., B, L., K, G., . . . DJ, S. (2023). Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 76(3), e477. https://doi.org/10.1093/cid/ciac372

Chicago Style (17th ed.) Citation

S, Shoham, et al. "Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 76, no. 3 (2023): e477. https://doi.org/10.1093/cid/ciac372.

MLA (9th ed.) Citation

S, Shoham, et al. "Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 76, no. 3, 2023, p. e477, https://doi.org/10.1093/cid/ciac372.